KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
Holding KALV?
Track your performance easily

KalVista Pharmaceuticals (KALV) Stock News & Sentiment

376 Followers
KalVista Pharmaceuticals Welcomes New CFO for Future Growth
Premium
Company Announcements
KalVista Pharmaceuticals Welcomes New CFO for Future Growth
24d ago
Is KALV a Buy, Before Earnings?
Premium
Pre-Earnings
Is KALV a Buy, Before Earnings?
1M ago
3 Best Stocks to Buy Now, 7/30/2024, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/30/2024, According to Top Analysts
2M ago
Is KALV a Buy, Before Earnings?
Premium
Pre-Earnings
Is KALV a Buy, Before Earnings?
3M ago
KalVista Pharmaceuticals Welcomes New Board Member
Premium
Company Announcements
KalVista Pharmaceuticals Welcomes New Board Member
5M ago
KalVista Pharmaceuticals Announces Executive Leadership Transition
Premium
Company Announcements
KalVista Pharmaceuticals Announces Executive Leadership Transition
7M ago
KalVista Pharmaceuticals Secures Funding to Advance Clinical Programs
Premium
Company Announcements
KalVista Pharmaceuticals Secures Funding to Advance Clinical Programs
8M ago
More KALV News >

News Score - Last 7 Days

Neutral
KALV
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KALV’s Media Buzz Sentiment?
3 articles about KALV were published this week. In an average week, 2.25 articles are published.
    What is KALV’s weekly average amount of articles?
    In an average week, 2.25 articles about KALV are published.
      What is KALV’s News Sentiment?
      50% of articles about KALV were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        FYBFormycon AG
        PRMEPrime Medicine, Inc.
        HUMHumana
        AMEDAmedisys
        BMYBristol-Myers Squibb
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis